RECRUITING

PPG to Predict Ejection Fraction and Other Echographic Data in the General Population

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The investigators are aiming to investigate the association between ejection fraction (EF) determined by echocardiography and signals obtained from Photoplethysmography (PPG) in the general population. The investigators are also aiming to investigate the association between blood pressure and signals obtained from PPG in the general population. Finally, the investigators are also aiming to investigate the association between signals obtained from PPG in the general population to cardioechographic findings such as, valvular heart disease, structural heart diseases, cardiomyopathies, pericardial disease etc.

Official Title

Photoplethysmography (PPG) to Predict Ejection Fraction and Other Echographic Data in the General Population

Quick Facts

Study Start:2021-08-20
Study Completion:2026-04
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04843371

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 120 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Male or Female aged18 years or older.
  2. * Patients scheduled to undergo an echocardiogram at Tulane Medical Center.
  1. * Participants under 18 years of age.
  2. * Participants with cognitive impairments.
  3. * Participants with a physical inability to wear the Biostrap during the echocardiogram.
  4. * Individuals who cannot read, speak, and/or understand English.

Contacts and Locations

Study Contact

Quintrele Jones, MPH
CONTACT
504-988-3063
qjones1@tulane.edu

Principal Investigator

Nassir Marrouche, MD
PRINCIPAL_INVESTIGATOR
Tulane University

Study Locations (Sites)

Tulane University Medical Center
New Orleans, Louisiana, 70112
United States

Collaborators and Investigators

Sponsor: Tulane University

  • Nassir Marrouche, MD, PRINCIPAL_INVESTIGATOR, Tulane University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-08-20
Study Completion Date2026-04

Study Record Updates

Study Start Date2021-08-20
Study Completion Date2026-04

Terms related to this study

Keywords Provided by Researchers

  • Structural heart disease
  • Photoplethysmography
  • Ejection Fraction

Additional Relevant MeSH Terms

  • Valvular Heart Disease
  • Pericardial Disease
  • Cardiomyopathies